These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated, perfused hearts. Takeo S; Tanonaka K; Hayashi M; Yamamoto K; Liu JX; Kamiyama T; Yamaguchi N; Miura A; Natsukawa T J Pharmacol Exp Ther; 1995 Jun; 273(3):1403-9. PubMed ID: 7791114 [TBL] [Abstract][Full Text] [Related]
16. The effect of K(atp)channel activation on myocardial cationic and energetic status during ischemia and reperfusion: role in cardioprotection. Fukuda H; Luo CS; Gu X; Guo L; Digerness SB; Li J; Pike MM J Mol Cell Cardiol; 2001 Mar; 33(3):545-60. PubMed ID: 11181022 [TBL] [Abstract][Full Text] [Related]
17. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy. Belardinelli R Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102 [TBL] [Abstract][Full Text] [Related]
18. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction. Rosano GM; Vitale C; Volterrani M Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895 [TBL] [Abstract][Full Text] [Related]
19. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy. Billman GE Pharmacol Ther; 2008 Oct; 120(1):54-70. PubMed ID: 18708091 [TBL] [Abstract][Full Text] [Related]
20. [Ion channels and arrhythmias]. Borchard U; Hafner D Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]